Treatment with B-type natriuretic peptide for chronic decompensated heart failure: Insights learned from the Follow-Up Serial Infusion of Nesiritide (FUSION) trial

Heart Failure Reviews

Volumn 9, Issue 3, 2005, Pages 209-216

  Yancy, Clyde W ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Heart failure; Inotropic therapy; Left ventricular dysfunction; Natriuretic peptide

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; CREATININE; CYCLIC GMP; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; INOTROPIC AGENT; MILRINONE; NESIRITIDE; NEUROHORMONE; PLACEBO; PROLINE; PROSTACYCLIN; SPIRONOLACTONE;

ARTICLE; BLOOD PRESSURE REGULATION; BOLUS INJECTION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONSENSUS; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART PROARRHYTHMIA; HEART TRANSPLANTATION; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HOSPITALIZATION; HUMAN; INOTROPISM; KIDNEY FAILURE; MORTALITY; OPEN STUDY; RISK ASSESSMENT; SYMPTOMATOLOGY; TREATMENT OUTCOME; VASODILATATION;

AGED; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 17144392549     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-005-6132-9     Document Type: Article

References (32)

1. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001 38 2101-2113
2. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987 316 1429-1435
3. Rales Investigators. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (The Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol 1996 78 902-907
4. Packer M, Fowler MB, Roecker EB, et al. for the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002 106 2194-2199
5. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991 325 1468-1475
6. Califf RM, Adams KF, McKenna WJ, et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J 1997 134 44-54
7. Rose EA, Moskowitz AJ, Packer M, et al., the REMATCH Investigators. The REMATCH trial: Rationale, design, and end points. Ann Thorac Surg 1999 67 723-730
8. Rose EA, Gelijns AC, Moskowitz AJ, et al. for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001 345 1435-144310.1056/ NEJMoa012175
9. Coffin MR. Dobutamine infusion for the treatment of congestive heart failure in the home care setting. J Intraven Nurs 1994 17 145-150
10. Harjai KJ, Mehra MR, Ventura HO, et al. Home inotropic therapy in advanced heart failure. Cost analysis and clinical outcomes. Chest 1997 112 1298-1303
11. McCloskey WW. Use of intravenous inotropic therapy in the home. American Journal of Health-Systems Pharmacy 1998 55 930-935
12. Krell MJ, Kline EM, Bates ER, et al. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. Am Heart J 1986 112 787-791
13. Marius-Nunez AL, Heaney L, Fernandez RN, et al. Intermittent inotropic therapy in an outpatient setting: A cost-effective therapeutic modality in patients with refractory heart failure. Am Heart J 1996 132 805-808
14. Miller LW, Merkle EJ, Herrmann V. Outpatient dobutamine for end-stage congestive heart failure. Crit Care Med 1990 18 S30-S33
15. Roffman DS, Applefeld MM, Grove WR, et al. Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure. Clin Pharm 1985 4 195-199
16. Van den Brande P, Van Mieghem W, Demedts M. Intermittent dobutamine infusion in severe chronic heart failure in elderly patients. Gerontology 1990 36 49-54
17. Boerrigter G, Burnett JC, Jr. Recent advances in natriuretic peptides in congestive heart failure. Expert Opin Investig Drugs 2004 13 643-652
18. Mills RM, Hobbs RE, Young JB. "BNP" for heart failure: Role of nesiritide in cardiovascular therapeutics. Congest Heart Fail 2002 8 270-273
19. Aronson D, Burger AJ. Intravenous nesiritide (human B-type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated congestive heart failure. Am J Cardiol 2002 90 435-438
20. Aronson D, Horton DP, Burger AJ. Nesiritide improves heart rate variability in patients with decompensated heart failure [abstract 4551]. J Am Coll Cardiol 2002 39 suppl B 403B
21. Brunner-La Rocca HP, Kaye DM, Woods RL, Hastings J, Esler MD. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol 2001 37 1221-1227
22. Yoshimura M, Yasue H, Morita E, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991 84 1581-1588 1:STN:280:By2D3cngsFM%3D
23. Marcus LS, Hart D, Packer M, et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. Circulation 1996 94 3184-3189
24. Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 1998 4 37-44
25. Tsuruda T, Boerrigter G, Huntley BK, et al. Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 2002 91 1127-1134
26. Colucci WS, Elkayam U, Horton DP, et al., for the Nesiritide Study Group. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 2000 343 246-253
27. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA 2002 287 1531-1540
28. Peacock WF, Emerman CL, on behalf of the PROACTION Study Group. Safety and efficacy of nesiritide in the treatment of decompensated heart failure in observation patients [abstract 1027-89]. J Am Coll Cardiol 2003 41SUPPL A 336A
29. Butler J, Emerman C, Peacock WF, Mathur VS, Young JB, on behalf of the VMAC Study Investigators. The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure. Nephrol Dial Transplant 2004 19 391-399
30. Burger AJ, Elkayam U, Neibaur MT, et al. Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. Am J Cardiol 2001 88 35-39
31. Burger AJ, Horton DP, LeJemtel T, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT Study. Am Heart J 2002 144 1102-1108
32. Yancy CW, Saltzberg MT, Berkowitz RL, et al. Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I Trial). Am J Cardiol 2004 94 595-601